Refractory evans syndrome after autologous stem cell transplantation for multiple myeloma: Management with a second transplantation

4Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

The development of autoimmune disease after autologous stem cell transplantation (ASCT) is very rare in multiple myeloma (MM). We describe the first case of Evans syndrome after ASCT for MM. A 60-year-old man with MM received ASCT and subsequently developed Evans syndrome following two febrile episodes. The syndrome was refractory to conventional therapies but it was managed with a second ASCT. This unique complication was thought to have been triggered by an infection during the recovery of the immune system. We assumed that reconstructing the immune system via ASCT might eliminate infection-induced autoantibodies to platelets and erythrocytes. © 2010 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Chihara, D., Sakamoto, T., Arimoto-Miyamoto, K., Kishimoto, W., Takeoka, T., Tsuji, M., & Ohno, T. (2010). Refractory evans syndrome after autologous stem cell transplantation for multiple myeloma: Management with a second transplantation. Internal Medicine, 49(7), 683–687. https://doi.org/10.2169/internalmedicine.49.2922

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free